A cell-based Dkk1 binding assay reveals
β
Richard J. Murrills; Jeanne J. Matteo; Bheem M. Bhat; Valerie E. Coleburn; Krist
π
Article
π
2009
π
John Wiley and Sons
π
English
β 276 KB
π 2 views
## Abstract Dkk1 is a secreted antagonist of the LRP5βmediated Wnt signaling pathway that plays a pivotal role in bone biology. Because there are no wellβdocumented LRP5βbased assays of Dkk1 binding, we developed a cellβbased assay of Dkk1/LRP5 binding using radioactive ^125^IβDkk1. In contrast to